Hudson Bay Capital Management
DOVA

Hudson Bay Capital Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Hudson Bay Capital Management’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,000
Closed -$271K – 1046
2018
Q1 		$271K Buy
+10,000
New +$299K 0.01% 715

Other funds holding DOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hudson Bay Capital Management's DOVA Position: Q2 2018 in Review

Hudson Bay Capital Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q2 2018, closing a stake of 10,000 shares — an estimated $271K sold.

Hudson Bay Capital Management first reported a position in DOVA in Q1 2018 and held it in 1 quarter. The position peaked at $271K in Q1 2018. 60 funds tracked by Wall St. Rank hold DOVA as of Q2 2018.

  • Hudson Bay Capital Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 10,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $271K.
  • Hudson Bay Capital Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Hudson Bay Capital Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $271K in Q1 2018.
  • 60 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on Hudson Bay Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.